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ABSTRACT
Motivation: The analysis of a number of different genetic features
like copy number (CN) variation, gene expression (GE) or loss
of heterocygosity has considerably increased in recent years, as
well as the number of available datasets. This is particularly due
to the success of microarray technology. Thus, to understand
mechanisms of disease pathogenesis on a molecular basis, e.g.
in cancer research, the challenge of analyzing such different data
types in an integrated way has become increasingly important. In
order to tackle this problem, we propose a new procedure for an
integrated analysis of two different data types that searches for
genes and genetic regions which for both inputs display strong
equally directed deviations from the reference median. We employ
this approach, based on a modiﬁed correlation coefﬁcient and an
explorative Wilcoxon test, to ﬁnd DNA regions of such abnormalities
in GE and CN (e.g. underexpressed genes accompanied by a loss of
DNA material).
Results: In an application to acute myeloid leukemia, our procedure
is able to identify various regions on different chromosomes with
characteristic abnormalities in GE and CN data and shows a higher
sensitivity to differences in abnormalities than standard approaches.
While the results support various ﬁndings of previous studies, some
new interesting DNA regions can be identiﬁed. In a simulation
study, our procedure also shows more reliable results than standard
approaches.
Availability: Code and data available as R packages edira and
ediraAMLdata from http://www.statistik.tu-dortmund.de/~schaefer/
Contact: martin.schaefer@udo.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Abnormalities in the human genome are known to have a major
impact on the susceptibility of developing tumors (Vogelstein and
∗To whom correspondence should be addressed.
Kinzler, 2004). Examples of such abnormalities are changes in copy
number (CN) and gene expression (GE), loss of heterocygosity or
alternative splicing. CN alterations are among the structural genetic
changes most investigated for their role in influencing cancer risk. It
has been found that CN alterations of oncogenes, tumor suppressor
genes and stability genes are responsible for cancer genesis at
various steps (Pinkel and Albertson, 2005).
CN alterations can modify the function of genes in many ways,
affect the dosage of the corresponding genes and can also influence
the structure and regulation of genes located further away. Recent
studies estimate that CN variants are responsible for >15% of
heritable variation in GE (Stranger et al., 2007), which in turn
controls the functions of the human organism. For cancer cells,
the impact of CN alterations on GE can be suspected to be even
stronger. It may be assumed that the integration of CN and GE data
can help to reveal ‘driver’ genes, i.e. genes causally involved in
cancer pathogenesis, as opposed to ‘passenger’ genes who mutate
during pathogenesis without favoring cancer (see, e.g. Haverty et al.,
2009).
While alterations of CN can sometimes be negatively associated
with expression levels of such genes that lie outside the
affected region (as described, e.g. in Lee et al., 2006), an
altered expression level of a gene is in general positively
associated with the CN corresponding to its locus: losses of
chromosomal material—provoked by monosomies, deletions or
unbalanced translocations—tend to reduce expression, while gains
of chromosomal material—provoked by trisomies, duplications or
unbalanced translocations—are likely to increase it (Pinkel and
Albertson, 2005). Based on this relation, we concentrate on finding
the genes for which GE as well as CN are abnormal, i.e. present a
notable deviation of individual patient values from the median of the
references, toward the same direction. A presence of such equally
directed abnormalities at a gene in DNA of cancer patients indicates
that it may be a ‘driver’ gene.
Two issues are important in characterizing an integrated analysis
of CN and GE. The first is whether CN and GE are considered
simultaneously, i.e. in a bivariate approach. Often they are not,
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opting instead for a two-step procedure in which initially regions
with predominant gains and losses of DNA material are identified
(e.g. via assignment of the calls ‘normal’, ‘gain’ or ‘loss’). Then
genes in these regions are tested for differential expression, or over-
and underexpressed genes are searched for separately, and eventually
a list of genes is obtained for which CN and GE are both abnormal.
Such two-step approaches have been proposed, e.g. by Bicciato
et al. (2009), Heidenblad et al. (2005), Orozco et al. (2009), van
Wieringen et al. (2006) and Yoshimoto et al. (2007). Many of these
procedures at some point use an arbitrary threshold for CN or GE
data, e.g. a quantile, to define abnormality. As a consequence, the
information on abnormalities is partially discretized, leading to a
loss of information and ignoring the amount of uncertainty involved
in the assignment of CN calls. In testing for differential expression,
a choice has to be made as to between which CN categories testing
should be carried out, while testing may not be possible for some
genes with an unfavorable call distribution of the patients. A two-
step approach described by van Wieringen and van de Wiel (2009)
employs call probabilities for CN data instead of calls to tackle some
disadvantages of two-step procedures, but still potentially needs to
exclude genes due to restrictions on the call probability distribution,
and has to take a decision as to which kind of abnormality (gain or
loss) should be considered for a specific gene. These disadvantages
can be avoided in a bivariate approach that directly assesses the joint
abnormality of CN and GE for genes (and genetic regions).
The type of relationship between CN and GE measured in an
integrated analysis is the second important issue. Often integrated
bivariate analyses of CN and GE focus on the dependence between
the two variables, i.e. they look for pairs of data points for which the
relation between the two variables is such that the behavior of one
can be deduced from the behavior of the other. Typical examples
are correlation (e.g. Gu et al., 2008; Kotliarov et al., 2009; Lee
et al., 2008) or regression analyses (e.g. Chu, 2007; Gu et al., 2008;
Menezes et al., 2009; Stranger et al., 2007). Berger et al. (2006)
proposed a generalized singular value decomposition algorithm that
iteratively selects genes with correlated patterns of variation for both
variables. Dependence as attested by such approaches, e.g. by a
significant Pearson’s correlation coefficient, does not imply that the
CN and GE values of the cases tend to differ considerably toward the
same direction from those in healthy individuals. On the contrary,
both variables may be very abnormal in this sense and still result in a
correlation or regression coefficient near zero (cf. Section 2.2). Thus,
analyzing the dependence between CN and GE can produce different
results than assessing equally directed abnormalities of both CN and
GE in comparison with reference data. We argue that the latter may
be most suitable for the identification of DNA regions that play an
important role in oncogenesis.
A few works have subsequently realized both a two-step analysis
and an analysis of dependence (e.g. Järvinen et al., 2006; Lipson
et al., 2004; Pollack et al., 2002; Tsukamoto et al., 2008).
To our best knowledge, the modified correlation approach
presented in this study is the first one that combines a bivariate
analysis with an assessment of the equally directed abnormality of
CN and GE, avoiding the discussed shortcomings of other methods.
We demonstrate the utility of the proposed methodology on a set
of patients suffering from acute myeloid leukemia (AML) and in a
simulation study, comparing it with two other standard methods.
The outline of this article is as follows. Section 2 introduces the
methodology, while Section 3 gives a description of the AML data.
In Section 4, the results of the application of our procedure to the
AML data are discussed and compared with the results of two other
methods. Finally, Section 5 presents conclusions and an outlook.
2 METHODS
2.1 Segmentation of CN data
CN and GE in general are measured on different platforms, i.e. possibly
not at the same locations and based on DNA sections of different lengths.
As a consequence of the differences in data structure, each GE value
has to be assigned a CN value prior to an integrated analysis. Different
approaches have been proposed for different platforms for this purpose:
Myllykangas et al. (2008), e.g. assign to each GE data point the value of
the closest available CN data point, whereas Järvinen et al. (2006) and
Tsafrir et al. (2006) use linear interpolation procedures. Another possibility
is to employ a segmentation algorithm on the raw CN data, denoising
them (Lai et al., 2005; for an integrated analysis of CN and GE, see, e.g.
Haverty et al., 2008). In estimating both the breakpoints at which the CN
changes and the respective constant CN values between those breakpoints,
the original nature of CN, i.e. integers that are constant over DNA segments,
can be partly recovered: while the resulting values can take any rational
number, they are a piecewise constant function of the location. In this
way, CN values are obtained for each GE data point. We follow the latter
approach and use the segmentation algorithm proposed by Huber et al.
(2006).
Segmentation algorithms are generally carried out on log2-ratios of patient
to reference data. This implies the strong assumption of equal breakpoints for
patients and references, which we avoid by segmenting log2-transformed raw
CN intensity data of both groups separately. Values of patients and controls
are related afterwards by the methodology presented in Section 2.2. In Huber
et al. (2006), the raw CN intensities of a given chromosome are modeled as
a piecewise constant function of the data points i=1,...,n, and the persons
j=1,...,m:
x˘ij =µjs +εij, ts ≤ i< ts+1,
where x˘ij is the log2-transformed raw CN intensity for person j at data point
i, while ts,s=2,...,S, are the segment boundaries, t1 =1 and tS+1 =n+1,
µjs is the expected CN intensity for person j in segment s.
In each case, we choose the model that minimizes the residual sum of
squares
RSS(t1,...,tS)=
S∑
s=1
m∑
j=1
ts+1−1∑
i=ts
(x˘ij −µˆjs)2.
As an estimator µˆjs for the expected CN intensity of person j in segment s,
Huber et al. (2006) use the arithmetic mean of its x˘ij in segment s. To
increase the robustness, we employ the median here and use only the
median intensities µˆjs in the further analysis. In Figure 1, raw CN intensities
and the corresponding µˆjs of one patient are exemplarily plotted for one
chromosome.
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Fig. 1. Example for segmentation of a patient’s raw CN intensity data for
a chromosome. The vertical dotted lines indicate the segment breakpoints,
the dashed lines the chromosome limits and the horizontal solid lines the
estimated CN, i.e. the median of the raw values in the segment.
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Fig. 2. The idea of the externally centered correlation coefficient. The CN and GE intensities of 33 patients are plotted for the 224963_at probe set (A) and
the 54970_at probe set (B) from the Affymetrix U133 chip set. The dotted and dot-dashed lines represent the median CN and GE intensities in the reference
dataset, respectively. G is their intersection. The solid line represents the line of a standard linear regression of GE intensity on CN intensity. The gray rectangle
indicates deviation of CN and GE from the median of the references for a single patient.
The only free parameter that remains in the model is S, the number of
segments. Huber et al. (2006) propose a penalized maximum likelihood
approach to choose the value of S and discuss Akaike’s information
criterion (AIC) or the Bayesian information criterion (BIC) to control the
overfitting due to too many segments, noting that the BIC works particularly
well in simulations. Following this argumentation, we use the BIC (for
an own comparison with the AIC, see Section 1 of the Supplementary
Material).
2.2 The externally centered correlation coefficient
Popular bivariate measures for assessing the association between CN and
GE are, e.g. Pearson’s correlation coefficient and the related approach of
regressing GE on CN. In our analysis, we modify Pearson’s correlation
coefficient in a way that permits to measure equally directed deviations of
CN and GE in patients from the median of the references.
In Figure 2, log2-transformed GE intensities and log2-transformed and
segmented CN intensities of two example genes are plotted for the patients.
In Figure 2A, the values of both inputs are smaller than in the reference data
for this locus, which therefore is an example for equally directed deviations
as we want to detect them. As the regression coefficient is almost zero,
though, a regression or correlation analysis in this case fails to indicate this
abnormality. In Figure 2B, an example for the reverse situation is given: the
regression coefficient is high but the deviations are not equally directed.
Assessing the association of CN and GE via regression or correlation
therefore may yield results contrary to those desired. Employing log2-ratios
of patients to controls instead of the raw CN values would not change the
significance of a correlation or regression coefficient.
Apparently, the degree of equally directed deviations from the median
of the references for a gene depends on the location of the patients’ values
relative to G, the coordinate defined by the median values of the reference
group (Fig. 2). If a patient’s values are located in the first or third quadrant,
they show deviations toward the same direction. If they are located in the
second or fourth quadrant, they show deviations toward opposite directions,
which means that we are not interested in detecting this data point. The
deviation increases with both the distance from G and the distance from the
two lines representing the medians of the references. Therefore, we propose
to use the area of the rectangles defined by G and each point representing a
patient to construct a deviation measure, as suggested in Figure 2.
Starting from Pearson’s well-known correlation coefficient, we substitute
the means over the cases’ CN or GE values by the respective medians of the
reference group to obtain a new measure, the externally centered correlation
coefficient. For random vectors X= (X1,...,Xm)T and Y= (Y1,...,Ym)T ,
it is thus defined as
rEC :=
∑m
j=1(Xj −A)(Yj −B)√∑m
j=1(Xj −A)2 ·
√∑m
j=1(Yj −B)2
. (1)
Here, Yj,j=1,...,m, represent the log2-transformed GE signals of the
patients and Xj,j=1,...,m, their CN signals estimated from the log2-
transformed CN intensities during the segmentation process, as described
in Section 2.1. U= (U1,...,Up)T consists of reference GE intensities and
V= (V1,...,Vt)T of reference CN intensities, m,p,t ∈N. Ideally, both are
available as paired values of a reference group (Uh,Vh),h=1,...,w,w=p=
t, but in other cases the analysis is possible as well. The patients’ values
are centered by the median value of the references for each variable. For
consistency with general practice, the median is calculated on the original
intensity scale, i.e. A= logMed(U) and B= logMed(V) with logMed(U)=
log2(median(2U)). We call the deviations from the reference median in CN
and GE, Xj −A and Yj −B, equally directed if they possess the same sign,
leading to a positive sign of rEC .
rEC yields values between −1 and 1 due to the Cauchy–Schwarz
inequality, as does Pearson’s correlation coefficient.
2.3 Wilcoxon test for symmetry
The externally centered correlation coefficient rEC assesses the deviations of
CN and GE intensities from the median of the references for single gene loci.
In addition, it is desirable to have a measure of randomness for the degree
to which the rEC values exceed zero. To achieve this goal, we suggest to use
the following test in an explorative way.
Consider the distribution of the summands Z1,...,Zm in (1), i.e.
Zj = (Xj −A)(Yj −B)√∑m
j=1(Xj −A)2 ·
√∑m
j=1(Yj −B)2
,j=1,...,m.
These summands in their absolute values correspond to the areas of the
rectangles defined by G and the patients’ values (Fig. 2).
Let the random variable Z represent the standardized rectangle areas in
the patients’ population, and view Z1,...,Zm as a random i.i.d. sample of
Z . If equally directed deviations in CN and GE intensities are present, we
expect the distribution of Z to be slanted toward positive values. This means
that at any point, the value of its cumulative distribution function is greater
than the one of the cumulative distribution function of −Z .
A permutation test, as used, e.g. in Tsukamoto et al. (2008) or van
Wieringen and van de Wiel (2009) in this situation is potentially problematic
as it implies that the empirical distribution of Z in the patients’ genome
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approximates the random case, which is uncertain for, e.g. study groups with
a high frequency of aberrations. As the distribution of the Zj for one gene is
not known either, a classical non-parametric test is proposed.
We thus use the Wilcoxon signed rank test which is a suitable test for the
null hypothesis
H0 :P(Z ≤x)=P(−Z ≤x) ∀x∈R
against the alternative
H1 :P(Z ≤x)>P(−Z ≤x) ∀x∈R
(Hollander, 2006). This test could be used to formally test the CN and GE
deviations from the reference median in single loci for equally directed
abnormalities. Since we, however, are interested in finding potentially
abnormal genetic regions, we use the P-values as an explorative measure
in the algorithm proposed in the next section.
2.4 Automatic detection of abnormal genetic regions
CN alterations and resulting GE changes can typically affect larger DNA
sequences. It is therefore desirable to extend the detection of deviations in
order to assess regions of neighboring genes. Lipson et al. (2004), e.g. use
a moving window for this purpose, whereas Kingsley et al. (2006) divide
the genome in 100 fixed bins. In the following, we discuss how results of
the test from Section 2.3 can be used in a more flexible algorithm without
fixed region widths to find regions on the DNA that show equally directed
abnormalities for CN and GE. The following criteria should be met by such
an algorithm:
• It should find those genetic regions that have a high concentration of
small P-values.
• The more the data points are contained in a region, the higher is the
evidence of abnormality in presence of a high proportion of small
P-values. Therefore, the algorithm should take into account the number
of data points in a region, i.e. of two regions showing similarly small
P-values, the one containing the most data points should be preferred.
• The chance for any region to be identified should not depend on its
length, i.e. short and long regions with a similar proportion of small
P-values should have equal probabilities of being found.
In practice, such an algorithm can be divided into two tasks: iteratively
searching for regions and checking whether found regions are sufficiently
abnormal, e.g. exceed some prespecified threshold. Different criteria may be
used for both tasks. Our algorithm is based on:
(a) the sum of the (previously transformed) P-values in a region as a
measure for the concentration of small P-values.
(b) the proportion κ/ς as a filter criterion, where κ is the number of a
region’s P-values below a threshold τ, and ς is essentially the number
of P-values in the whole genome. We require κ/ς≥π for a region to be
identified. τ and π represent the permeability of the filter through which
we pass the regions in order to check for their abnormality. Speaking
in images, by choosing τ, one can ‘raise the bar’, while π determines
which proportion of the loci should pass it.
A detailed and formal description of the algorithm and the exact
calculation of π and τ can be found in Sections 2 and 3 of the Supplementary
Material.
3 DATA
In the following, the proposed method is applied to data from
a collective of 33 patients suffering from AML that show a
complex aberrant karyotype. AML patients often have characteristic
cytogenetic abnormalities that are associated with specific disease
subtypes and play an important role in survival prognosis. For this
dataset, a prior analysis (Merk et al., 2007) found a noticeable
reduction of GE intensity as well as DNA losses on the long
arm of chromosome 5. These changes are among the most
frequent chromosomal aberrations in AML with a complex aberrant
karyotype and are, like this karyotype as a whole, associated with a
poor prognosis (Haferlach et al., 2004; Schoch et al., 2005).
Between 1999 and 2003, the 33 AML patients (21 males,
mean age: 63.4) were assessed in German medical practices. The
reference measurements for GE intensity were taken from 11 healthy
individuals (5 males, mean age: 40.0, with age missing for one
subject) between 2001 and 2003, while for CN intensity they were
taken from 2 healthy individuals (1 male, mean age: 30.4) in 2005.
All measurements were taken in the same laboratory. Differences
between the datasets with respect to age and gender distribution
are not considered harmful for CN intensity as it is associated with
neither of the two. Possible increases in variance of GE intensity
over age (Somel et al., 2006) are eliminated during preprocessing.
Genes may be differentially expressed between men and women, but
studies indicate that only very few genes are likely to be affected,
especially if the sex chromosomes are not considered (McRae et al.,
2007; Whitney et al., 2003). Thus, a possible stratification for gender,
drastically reducing the sample size, does not appear convenient.
DNA was isolated from AML cells and subjected to the Mapping
10K 2.0 Array (CN) and the Human Genome U133 Array Set (GE),
respectively. Details on the Affymetrix GeneChip technology can be
found in Affymetrix (2003).
4 RESULTS
All calculations were carried out using the statistical software
environment R, version 2.9.1 (R Development Core Team, 2009).
Background correction, normalization and summarization for GE
data are conducted using RMA (Irizarry et al., 2003) as implemented
in the R package affy. The data points, i.e. probe sets that do not map
uniquely to the genome or that map to one of the sex chromosomes
or the mitochondrion genome are excluded. The positions of the
remaining 12 811 probe sets from the Human Genome U133 Array
Set that serve as the elementary units in our analysis are obtained
from the BioMart data management system (December 2008 freeze;
http://www.biomart.org/).
The CN intensity data are preprocessed using the CRMA
method in the R package aroma.affymetrix (Bengtsson et al.,
2008a). We follow the procedure described in Bengtsson et al.
(2008b) to perform allelic crosstalk calibration, summation of
allele signals, robust probe-level modeling and PCR fragment-
length normalization. Finally, the resulting intensity values are
log2-transformed. Data of patients and references are processed
separately in this way, then the segmentation algorithm described in
Section 2.1 is carried out on both the datasets, choosing the BIC as
penalization term (see Section 1 of the Supplementary Material for
details). To each GE probe set and its corresponding GE intensity,
we assign the CN intensity estimated for the middle between its
beginning and end points. The SNP positions are retrieved from
Affymetrix annotation files, additional annotation is obtained from
the UCSC Genome Bioinformatics database (December 2008 freeze;
http://genome.ucsc.edu/).
For the matched CN and GE values, the values of rEC are
computed. In Figure 3A, these values, considering the AML patients
compared with healthy individuals, are shown. This figure reveals
that chromosome 5 shows the highest values in the genome.
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Fig. 3. Values of rEC (A) and P-values of the Wilcoxon test (B), plotted on a −log10 scale. Dashed lines separate the chromosomes, dotted lines separate
their respective p and q arms. The loci are represented by different colors according to the coordinate corresponding to their median CN and GE values. If it
falls into the first of the quadrants defined by the median CN and GE values of references, the probe set is marked by a red point, indicating increased CN
intensity combined with increased GE intensity. Black points indicate the third quadrant (both CN and GE intensity reduced), blue points indicate the second
quadrant and orange points the fourth quadrant. The plotting positions on the x-axis are the middle positions of the probe sets. In (B), regions identified as
abnormal toward equal directions (τ=10−6, π = 0.01) are marked by a yellow background.
The probe sets on its q arm predominantly display a loss of DNA
material accompanied by reduced GE, which is consistent with
the findings of Merk et al. (2007). Large regions can be seen
in which probe sets with either increased or reduced CN, but
diverse GE behavior dominate. This makes sense as segmented CN
intensities have a smaller variance than GE intensities. As we focus
on equally directed deviations from the median of the references, we
concentrate on the positive values of rEC , i.e. concordant increase
(red) or concordant reduction (black).
The values of rEC are reflected in the P-values of the exploratively
conducted Wilcoxon test, as shown in Figure 3B. Here, several
deviations appear far more notable than suggested by the values of
rEC . The reason is that the denominator of rEC shrinks the measure
in its numerator more for probe sets for which the patients’ values
deviate highly from the median of the references. Since this effect
is not relevant for the test’s null hypothesis of symmetry, it is not
reflected by the P-values. Thus, while rEC is a well-interpretable
coefficient to measure deviations of CN and GE intensities, the test
is a valuable, further improved measure for assessing them with
respect to equally directed deviations from the reference median.
More detailed results for each chromosome are shown in Section 5
of the Supplementary Material.
We also apply a correlation procedure similar to the one described
by Tsukamoto et al. (2008) and the two-step procedure of van
Wieringen and van de Wiel (2009) to the AML dataset (for
detailed descriptions and results, see Section 4 of the Supplementary
Material). These procedures seem less able to separate regions that
display a high versus low degree of equally directed deviations, as
their results are less distinguished between the chromosomes (cf.
Supplementary Figs 3 and 4). Their P-values are not only low for
loci at which the majority of CN and GE values display equally
directed abnormalities, but also in cases of abnormalities toward
opposite directions, which is not desirable.
We conduct our algorithm for finding regions of equally directed
abnormalities on the P-values of the Wilcoxon test (see Section 2.4
and Algorithm 1 in Section 2 of the Supplementary Material which
also contains a detailed description of the approach). To show how
the different degrees of abnormality of regions can be explored by
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varying τ and π, we start with τ=10−3 and π=0.01, then reduce τ
first to 10−4 and then to 10−6 (while keeping π=0.01), gradually
raising the degree of abnormality. For further adjustment, we raise
π to 0.03 such that the abnormality of the found regions increases
further. The found regions for each parameter specification are given
in Table 1 (for the choice of further parameters, see Section 3 in
the Supplementary Material). In Figure 3B, the found regions for
τ=10−6 and π=0.01 are marked yellow.
These findings support various results of previous studies about
CN changes in AML. On chromosome 5q, 7p and 17p, we find
regions with strong concordant reductions of CN and GE. These
regions have been found to show the most frequent abnormalities in
AML with complex aberrant karyotype (see, e.g. Haferlach et al.,
2004; Schoch et al., 2005). Gain of DNA material is observed less
frequent in this karyotype, but still considerably often. In particular,
it occurs on chromosomes 8 and 11 (Mrózek, 2008) on which we also
detect regions of concordant increase of CN and GE. In summary,
most of the regions we detect as representing a concordant reduction
or increase of CN and GE intensities have been discussed in recent
literature. Our approach is thus able to find abnormal regions shared
by a considerable number of individuals in a study group.
However, there are also some differences between the general
picture in literature and our findings. On the one hand, for example,
many studies list DNA amplifications and increases of GE intensity
on the q arms of chromosomes 20 and 21, which we do not
identify. On the other hand, notable regions we find on the p
arm of chromosome 7 (concordant reduction) and on the q arm
of chromosome 12 (concordant increase) have not been previously
discussed (Mrózek, 2008).
The algorithm’s findings based on the other methods (see
Section 4 of the Supplementary Material) match to some extent with
the regions we find when applying it to the P-values resulting from
testing rEC with the Wilcoxon test. For example, the abnormality
regions on chromosome 5 are also detected when considering the
P-values from the other methods. However, there are also striking
differences; the abnormalities on chromosomes 7p, 12q and 17p
that are noticeable in our results are missing in those of both other
methods.
We furtherly conduct a simulation study to compare our approach
with the two other methods. The results (to be found in Section 4
of the Supplementary Material, together with a detailed description
of the study) indicate that our approach is better able to measure
equally directed deviations from the median of references in CN
and GE data than the other methods. In particular, our approach is
less prone to bias due to values that do not share the deviation pattern
of a majority of patients for a locus.
5 DISCUSSION
The increase of data on different genetic features creates the need for
concepts for their integrated analysis. These analyses might help to
understand more completely the effects and interactions of different
types of genomic variation with respect to disease risk. DNA CN
and GE are among the most investigated types of variation in cancer
research. An increased CN is one of the main causes that induces a
higher expression of the corresponding gene, while a reduced CN
can lower the GE. Equally directed abnormalities of CN and GE, i.e.
a concordant increase or a concordant reduction of both variables,
in patients compared with references may thus help to identify
Table 1. Abnormal regions as identified by Algorithm 1 (Supplementary
Material)
Chromo-
some
Direction Regions found with different parameter values
τ=10−3 τ=10−4 τ=10−6 τ=10−6
π=0.01 π=0.01 π=0.01 π=0.03
2 + 17–29
+ 39–56 39–56
+ 61–76 61–76
5 − 50–116 50–116 89–116
− 130–144 130–144 130–144 130–144
− 147–159 147–159 147–159
− 172–181 172–181
6 + 25–38 25–38
+ 41–54 41–54
7 − 1–10 1–10
− 19–48 19–48 19–32
− 72–112 72–112
− 119–131 119–131
− 133–144 133–144
− 148–157
8 + 95–106
9 + 27–38
+ 99–140 128–140
10 + 69–78
+ 94–106 94–106
11 + 60–81 60–70
+ 113–125 113–125
12 + 47–57 47–57 47–57
+ 108–120 108–120 108–120
15 − 67–72
16 − 65–73
− 83–89
17 − 3–11 3–11 3–11 3–11
− 25–32
− 34–49
19 + 12–19
The rows show the regions (in Mb), the columns show four different specifications of
τ and π. The second column shows the direction of the abnormalities, i.e. concordant
reduction (−) or concordant increase (+) of CN and GE.
‘driver’ genes that are causally related to disease development. We
introduced an approach based on the externally centered correlation
coefficient, a new measure that assesses the degree to which CN and
GE are both altered toward the same direction for a given locus. We
provide a Wilcoxon test to assess whether positive deviations from
zero are random in the coefficient’s values, as well as an algorithm
to define abnormality for regions encompassing various genes in an
explorative way.
Other methods in general either assess CN and GE abnormalities
only consecutively for one variable at a time, losing information,
or measure the dependence between CN and GE in a correlation or
regression analysis, which does not inform about actual deviations
between values from diseased and healthy persons. The ability
of our approach to identify regions of concordant abnormality
is demonstrated on a group of leukemia patients that were
previously found to have characteristic losses of DNA material on
chromosome 5. Our procedure identifies this region as abnormal, as
well as further regions that have been addressed in other studies.
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In addition, some regions are found that have not been discussed
previously, which indicates that our procedure can provide new
insights to the interplay between chromosomal mutations and GE in
cancerogenesis and helps to develop new hypotheses.
On the AML dataset and in a simulation study, our method
outperformed two standard approaches with respect to separating
regions of strong equally directed abnormalities from the other
regions (see Section 4 in the Supplementary Material).
It is strongly recommended to use paired data for the patients
as well as for the control group; nevertheless, in case of data
shortage CN and GE reference data can also come from two
different groups for our approach as the reference values enter in an
aggregated way. Unless more standardized protocols are widely used
in laboratories, it is advisable to use reference data from the same
platform and laboratory to avoid bias (see, e.g. Sherlock, 2005).
Ideally, a greater number of reference samples than we used here
should be incorporated.
Since many collectives—in particular of patients with a complex
aberrant karyotype—are very heterogenous, a useful extension of
our method would be to enable the search of abnormalities that are
prevalent only in different (unknown) subgroups of patients.
While we focused on assessing equally directed abnormalities of
CN and GE at the same loci, the externally centered correlation
coefficient can also be used for assessing abnormality of one gene’s
CN with all other genes’ expression, as was done, e.g. in Lee
et al. (2008) or Stranger et al. (2007). This may lead to a fruitful
investigation of CN’s impact on gene structure and regulation as
well as interaction between genes.
Our approach could also be used to integrate other types of data,
responding to an increasing general need to integrate various data
sources. It is not limited to a special platform and also suited for
microarrays of higher resolution than those used here.
We used a Wilcoxon test based on the externally centered
correlation coefficient for explorative search of DNA regions with
equally directed deviations from the reference median in CN and GE,
which is feasible for relatively small sample sizes. The test could
also be used to investigate confirmatory hypotheses with respect to
the abnormality of certain genes (or genetic regions). In this case, it
would be necessary to adjust the P-values for multiple comparisons.
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